Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes
- Author
- IOZZO, Patricia1 2 ; HALLSTEN, Kirsti1 ; NUUTILA, Pirjo1 6 ; OIKONEN, Vesa1 ; VIRTANEN, Kirsi A1 ; PARKKOLA, Riitta3 ; KEMPPAINEN, Jukka1 ; SOLIN, Olof1 ; LONNQVIST, Fredrik4 ; FERRANNINI, Ele2 5 ; KNUUTI, Juhani1
[1] Turku PET Centre, Department of Nuclear Medicine, University of Turku, Turku, Finland
[2] Institute of Clinical Physiology, PET Centre, National Research Council (CNR), Pisa, Italy
[3] Department of Radiology, University of Turku, Turku, Finland
[4] Department of Medicine, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden
[5] Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy
[6] Department of Medicine, University of Turku, Turku, Finland - Source
Diabetes care. 2003, Vol 26, Num 7, pp 2069-2074, 6 p ; ref : 27 ref
- CODEN
- DICAD2
- ISSN
- 0149-5992
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- American Diabetes Association, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Biguanides Captation Chimiothérapie Diabète non insulinodépendant Foie Glucose Graisse viscérale Insuline Metformine Rosiglitazone Thiazolidinedione dérivé Tissu adipeux Traitement Diabète type 2 Endocrinopathie
- Keyword (en)
- Biguanides Uptake Chemotherapy Non insulin dependent diabetes Liver Glucose Visceral fat Insulin Metformin Rosiglitazone Thiazolidinedione derivatives Adipose tissue Treatment Type 2 diabetes Endocrinopathy
- Keyword (es)
- Biguanidas Captación Quimioterapia Diabetes no insulinodependiente Hígado Glucosa Grasa visceral Insulina Metformina Rosiglitazona Tiazolidinediona derivado Tejido adiposo Tratamiento Diabetes de tipo 2 Endocrinopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02O Hormones. Endocrine system
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01C Management. Various non-drug treatments. Langerhans islet grafts
- Discipline
- Endocrinopathies Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 14950830
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2337/diacare.26.7.2069 
https://dx.doi.org/10.2337/diacare.26.7.2069
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2069\";s:8:\"\u0000*\u0000epage\";s:4:\"2074\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"IOZZO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Patricia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:16:\"HALLSTEN, Kirsti\";i:1;s:14:\"NUUTILA, Pirjo\";i:2;s:13:\"OIKONEN, Vesa\";i:3;s:17:\"VIRTANEN, Kirsi A\";i:4;s:16:\"PARKKOLA, Riitta\";i:5;s:17:\"KEMPPAINEN, Jukka\";i:6;s:11:\"SOLIN, Olof\";i:7;s:18:\"LONNQVIST, Fredrik\";i:8;s:15:\"FERRANNINI, Ele\";i:9;s:14:\"KNUUTI, Juhani\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2069\";s:8:\"\u0000*\u0000epage\";s:4:\"2074\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"IOZZO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Patricia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:16:\"HALLSTEN, Kirsti\";i:1;s:14:\"NUUTILA, Pirjo\";i:2;s:13:\"OIKONEN, Vesa\";i:3;s:17:\"VIRTANEN, Kirsi A\";i:4;s:16:\"PARKKOLA, Riitta\";i:5;s:17:\"KEMPPAINEN, Jukka\";i:6;s:11:\"SOLIN, Olof\";i:7;s:18:\"LONNQVIST, Fredrik\";i:8;s:15:\"FERRANNINI, Ele\";i:9;s:14:\"KNUUTI, Juhani\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2069\";s:8:\"\u0000*\u0000epage\";s:4:\"2074\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"IOZZO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Patricia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:16:\"HALLSTEN, Kirsti\";i:1;s:14:\"NUUTILA, Pirjo\";i:2;s:13:\"OIKONEN, Vesa\";i:3;s:17:\"VIRTANEN, Kirsi A\";i:4;s:16:\"PARKKOLA, Riitta\";i:5;s:17:\"KEMPPAINEN, Jukka\";i:6;s:11:\"SOLIN, Olof\";i:7;s:18:\"LONNQVIST, Fredrik\";i:8;s:15:\"FERRANNINI, Ele\";i:9;s:14:\"KNUUTI, Juhani\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2069\";s:8:\"\u0000*\u0000epage\";s:4:\"2074\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"IOZZO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Patricia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:16:\"HALLSTEN, Kirsti\";i:1;s:14:\"NUUTILA, Pirjo\";i:2;s:13:\"OIKONEN, Vesa\";i:3;s:17:\"VIRTANEN, Kirsi A\";i:4;s:16:\"PARKKOLA, Riitta\";i:5;s:17:\"KEMPPAINEN, Jukka\";i:6;s:11:\"SOLIN, Olof\";i:7;s:18:\"LONNQVIST, Fredrik\";i:8;s:15:\"FERRANNINI, Ele\";i:9;s:14:\"KNUUTI, Juhani\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.2337\/diacare.26.7.2069\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:9:\"\u0000*\u0000jtitle\";s:13:\"Diabetes care\";s:9:\"\u0000*\u0000stitle\";s:13:\"Diabetes care\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2069\";s:8:\"\u0000*\u0000epage\";s:4:\"2074\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-5992\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"IOZZO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Patricia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:16:\"HALLSTEN, Kirsti\";i:1;s:14:\"NUUTILA, Pirjo\";i:2;s:13:\"OIKONEN, Vesa\";i:3;s:17:\"VIRTANEN, Kirsi A\";i:4;s:16:\"PARKKOLA, Riitta\";i:5;s:17:\"KEMPPAINEN, Jukka\";i:6;s:11:\"SOLIN, Olof\";i:7;s:18:\"LONNQVIST, Fredrik\";i:8;s:15:\"FERRANNINI, Ele\";i:9;s:14:\"KNUUTI, Juhani\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DICAD2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic Glucose uptake and their relation to visceral fat in type 2 diabetes\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
